Clay Marsh Talks Personalized Medicine | GenomeWeb

In a recent MedCity News interview, the Ohio State University Medical Center's Clay Marsh described his institution's "push into personalized medicine," though he said that the term connotes different meanings. "To some, personalized medicine means genomic medicine. Others might see it as patient-centered medicine," he said. Whichever the case, at present, personalized medicine "focuses on disease-based care," Marsh told MedCity News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.